BioVoice News eMag October 2023 | Page 43

“ We empower healthcare with AI-driven innovations ”

Amit Gandhi , Chief Business Officer , DeepTek . ai talks about his company ’ s focus on developing unique health technologies and products besides its expansion plans

By Rahul koul

Kindly share a few interesting facts about DeepTek . ai and the key milestones achieved so far ?
Founded in 2017 , DeepTek . ai is amongst very few Radiology AI startups , which has successfully established commercial adoption of AI technology in clinical practice – creating clear and quantifiable value for patients , hospitals , and radiologists .
At the forefront of our achievements is AugmentoTM , a US FDA cleared Radiology AI deployment platform . It represents a revolutionary convergence of smart reporting and cutting-edge AI technology , orchestrating a seamless optimization of radiology workflows .
GenkiTM , an AI-powered lung health screening solution by Deeptek . ai has ushered in a new era of precision diagnosis and care . In the ongoing TB Free initiative run by Greater Chennai Corporation ( GCC ) over 300,000 people have been screened since 2019 using the GenkiTM solution .
While AI can often appear as a ' black box ', DeepTek . ai defies convention with its pioneering work in providing Responsible AI solutions . This integral feature suite within our solutions has garnered immense praise from medical professionals utilizing our services especially in Singapore .
DeepTek . ai ' s journey is reinforced by esteemed equity partners such as TATA Capital Healthcare Fund II and NTT DATA , attesting to our vision and credibility . The company has established strategic collaborations with both Shimadzu Middle East & Africa and Shimadzu Asia Pacific .

HealthTech

BIOVOICENEWS . COM 43